GWPH - GW Pharmaceuticals EPS misses by $0.02 beats on revenue February, 16 2021 07:10 AM GW Pharmaceuticals Plc GW Pharmaceuticals (GWPH): Q4 GAAP EPS of -$0.08 misses by $0.02.Revenue of $148.2M (+35.8% Y/Y) beats by $3.66M.Press Release For further details see: GW Pharmaceuticals EPS misses by $0.02, beats on revenue